Anika Therapeutics (ANIK) Change in Acquisitions & Divestments (2016 - 2021)
Anika Therapeutics (ANIK) has disclosed Change in Acquisitions & Divestments for 7 consecutive years, with $2.5 million as the latest value for Q1 2021.
- Quarterly Change in Acquisitions & Divestments fell 83.32% to $2.5 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2021, down 94.44% year-over-year, with the annual reading at $2.5 million for FY2021, 94.44% down from the prior year.
- Change in Acquisitions & Divestments for Q1 2021 was $2.5 million at Anika Therapeutics, down from $18.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $58.8 million in Q4 2019, with the low at $2.5 million in Q1 2021.
- Average Change in Acquisitions & Divestments over 5 years is $16.6 million, with a median of $11.5 million recorded in 2018.
- The sharpest move saw Change in Acquisitions & Divestments surged 411.06% in 2019, then plummeted 83.32% in 2021.
- Over 5 years, Change in Acquisitions & Divestments stood at $10.2 million in 2017, then grew by 12.2% to $11.5 million in 2018, then soared by 411.06% to $58.8 million in 2019, then tumbled by 69.37% to $18.0 million in 2020, then plummeted by 86.11% to $2.5 million in 2021.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $2.5 million, $18.0 million, and $7.0 million for Q1 2021, Q4 2020, and Q3 2020 respectively.